Medpace Investors, LLC - Nov 29, 2023 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Role
10%+ Owner
Signature
/s/ Stephen P. Ewald, Authorized Signatory for Medpace Investors, LLC
Stock symbol
MEDP
Transactions as of
Nov 29, 2023
Transactions value $
-$14,507,101
Form type
4
Date filed
12/1/2023, 04:25 PM
Previous filing
Nov 29, 2023
Next filing
Feb 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MEDP Common Stock Sale -$864K -3.17K -0.06% $272.87 5.64M Nov 29, 2023 Direct F1, F2
transaction MEDP Common Stock Sale -$4.93M -18.1K -0.32% $272.62 5.62M Nov 29, 2023 Direct F1, F3
transaction MEDP Common Stock Sale -$2.14M -7.87K -0.14% $272.18 5.61M Nov 30, 2023 Direct F1, F4
transaction MEDP Common Stock Sale -$6.57M -24K -0.43% $273.26 5.59M Dec 1, 2023 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
F2 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.06 to $273.955. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
F3 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.00 to $274.415. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
F4 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.00 to $273.75. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
F5 The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $272.00 to $274.565. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.